Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40024314
Localisation
Japan
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
18/12/2025
Statut
Classification
1.5°C
Année cible
FY2030
Near-Term Targets: MEDISCIENCE PLANNING INC. commits to reduce absolute scope 2 GHG emissions 42.0% by FY2030 from a FY2024 base year. MEDISCIENCE PLANNING INC. also commits to reduce absolute scope 3 GHG emissions 25.0% within the same timeframe.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques